Gabren
Gabren Uses, Dosage, Side Effects, Food Interaction and all others data.
Gabren is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. In clinical trials, progabide has been investigated for Parkinson's disease, schizophrenia, clinical depression and anxiety disorder; its therapeutic effectiveness in these conditions is not fully elucidated.
Gabren, a fatty acid derivative, is a GABA receptor agonist used to treat the symptoms of epilepsy.
Trade Name | Gabren |
Generic | Progabide |
Progabide Other Names | Halogabide, Progabida, Progabide, Progabidum |
Type | |
Formula | C17H16ClFN2O2 |
Weight | Average: 334.78 Monoisotopic: 334.0884336 |
Protein binding | 95% |
Groups | Experimental |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Indicated for the treatment of epilepsy.
How Gabren works
Gabren binds to both GABAA and GABAB receptors located on the terminals of primary afferent fibers. Binding to GABAA results in an increased affinity of the GABA receptor for the amino acid, an augmented flux of chloride ions across the terminal membrane, and an increase in the amount of presynaptic inhibition. Activation of the GABAB receptors retards the influx of calcium ions into the terminals, thereby reducing the evoked release of excitatory amino acids and possibly other transmitters.
Elimination Route
Well absorbed with a bioavailability of 60%
Half Life
4 hours
Innovators Monograph
You find simplified version here Gabren